Techlife Capital

Quinten is a technology-driven company delivering AI-powered real-world data analytics and advisory services in health and finance. In health, Quinten provides an integrated care and precision medicine platform that uses artificial intelligence and real-world data science to support treatments and patient care. It offers high-performance, interpretable patient profiling and develops, trains, and validates machine-learning models aimed at earlier, more accurate disease diagnosis. The company serves drug and medical device developers, care providers, and health agencies with disease-centric analytics across therapeutic areas such as oncology, rare diseases, endocrinology, cardiovascular, neurology, immunology, infectious diseases, gastroenterology and respiratory. In finance, Quinten Finance provides customized financial consulting solutions to aid decision making.

Flash Therapeutics specializes in genomic medicine, utilizing viral vector technologies to develop gene therapies. It offers solutions such as gene silencing, over-expression, cell-based assay development, protein expression, and preclinical trials. The company manufactures ready-to-use lentiviral particles for cellular reprogramming and fluorescent protein expression.